Lv1
18 积分 2023-11-04 加入
Antibody-Drug Conjugates and Ocular Toxicity
16天前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
19天前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
19天前
已完结
Atrasentan in Patients with IgA Nephropathy
25天前
已完结
Atrasentan in Patients with IgA Nephropathy
25天前
已完结
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
26天前
已完结
The Selective Endothelin Receptor Antagonist SC0062 in IgA Nephropathy
26天前
已关闭
Revisions to the Declaration of Helsinki on Its 60th Anniversary
29天前
已完结
Efficacy and Safety of Nefecon in Patients with Immunoglobulin A Nephropathy from Mainland China: 2-Year NefIgArd Trial Results
1个月前
已完结
Effects of Zibotentan Alone and in Combination with Dapagliflozin on Fluid Retention in Patients with CKD
1个月前
已关闭
皖公网安备34019202002308
